Key Takeaways CONMED reported Q4 adjusted EPS of $1.43, surpassing estimates on strong surgical segment performance.CNMD's Q4 revenue rose to$373.2 million, led by Orthopedic and General Surgery product line strength.CONMED's gross margin expanded 116 bps to 58.5%, reflecting improved profitability in Q4.CONMED Corporation (CNMD) delivered adjusted earnings per share (EPS) of $1.43 in the fourth quarter of 2025, up 6.7% year over year. The figure beat the Zacks Consensus Estimate by 8.6%.The adjustments in ...